The Parkinson’s Protocol™ By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease. The creator of this program has divided into four segments to cover a complete plan to treat this disease along with improving your health and life by knowing everything about this health problem. The main focus of this program is on boosting the levels of hormone in your brain by making e a few easy changes in your lifestyle, diet, and thoughts
What is the prevalence of Parkinson’s disease in Asia?
The prevalence of Parkinson’s disease (PD) in Asia varies across countries and regions based on age structure, genetic predisposition, and healthcare access. In general, Parkinson’s disease is lower in frequency in Asia compared with Western countries, although this discrepancy is decreasing as the population becomes older and awareness of the disorder increases.
Following is a summary of the prevalence of Parkinson’s disease in several regions of Asia:
1. East Asia (China, Japan, Korea):
China: The prevalence of Parkinson’s disease in China is on the rise due to the accelerated growth of China’s aging population. In the Journal of Parkinson’s Disease, it was estimated that the age-standardized prevalence of PD in China is roughly 1.7 to 2.3 per 1,000 people, with an augmented prevalence in older age ranges. Prevalence is greater in urban areas compared to rural areas, likely due to increased access to healthcare and diagnosis.
Japan: The population of Japan has one of the highest lifespans globally, and Parkinson’s disease is far from unknown. The prevalence rate for Parkinson’s disease in Japan is about 1,200 per 100,000 individuals above the age of 60. Japan’s high percentage of elderly individuals and remarkable development in the availability of diagnosing neurological disorders have led to a relatively high number of cases of Parkinson’s disease throughout the country.
South Korea: The prevalence of Parkinson’s disease has been estimated to be approximately 0.4–0.6% in the population over 60 years old. Prevalence increases with age as it does in other countries.
2. Southeast Asia (India, Indonesia, Thailand, Malaysia):
India: Indian studies estimate the occurrence of Parkinson’s disease at approximately 50-150 per 100,000 population in the general population but increases with increasing age. Parkinson’s disease is underdiagnosed in India, particularly among rural communities, due to limited access to healthcare and awareness. As the population ages, there will be a marked rise over the next decade or so.
Indonesia and Thailand: The prevalence of Parkinson’s disease in Southeast Asia is generally lower than that in Western countries. For Indonesia and Thailand, the figure is 1.0–1.5 per 1,000 in the general population, with increased prevalence with age. Medical and cultural factors lead to some underreporting and late detection.
Malaysia: In Malaysia, the prevalence of Parkinson’s disease is estimated to be around 100-150 per 100,000 population in the general population. Incidence is higher in older age groups, and there are more efforts to raise awareness of Parkinson’s disease and improve diagnostic practices.
3. South Asia (Pakistan, Bangladesh, Sri Lanka):
Pakistan: Parkinson’s disease prevalence in Pakistan has been estimated at 10–20 per 100,000 population. The disease is underdiagnosed to some extent because of the lack of awareness and poor healthcare facilities in rural settings. With the aging population, the cases of Parkinson’s are likely to rise in the next few decades.
Bangladesh: There is not much data available on the incidence of Parkinson’s disease in Bangladesh, but it is believed to be low compared with Western countries. The increasing number of older individuals may lead to more diagnoses of Parkinson’s in the future, but access to health care remains an issue.
Sri Lanka: Sri Lankan studies have reported that the prevalence of Parkinson’s disease is estimated at 50–100 per 100,000 population, with prevalence increasing with age. As in other countries of South Asia, there is underreporting of the condition and a low rate of specialist care availability.
4. Central Asia (Kazakhstan, Uzbekistan, Turkmenistan):
Epidemiological data on Central Asian Parkinson’s disease prevalence are scarce, and available studies indicate lower prevalence rates compared to Western nations. Overall prevalence in nations such as Kazakhstan and Uzbekistan is thought to approximate other developing areas, with rising cases as the population grows older.
5. Asia as a Whole:
The general prevalence of Parkinson’s disease throughout Asia is about 0.1% to 0.5% of the population. Prevalence varies greatly regionally, and East Asia and some Southeast Asian countries have increased prevalence because they have aging populations and improved health care and diagnostic methods.
Factors Affecting Regional Differences
Aging Population: The rising number of elderly people in countries like Japan, China, and South Korea is a cause of the growing prevalence of Parkinson’s disease because the disease primarily affects older people.
Underdiagnosis: The disease is underdiagnosed in the majority of countries with limited access to healthcare or low awareness of Parkinson’s disease (rural India and Bangladesh), thus leading to fewer reported prevalence.
Healthcare Access: Countries with improved access to healthcare, such as Japan and South Korea, have increased incidence rates of Parkinson’s disease because of improved treatment and diagnostic capabilities.
Cultural Factors: Neurological conditions may be underreported or stereotyped in some regions, affecting the accuracy of prevalence estimation.
Conclusion
Parkinson’s disease incidence in Asia is increasing mainly due to aging populations and improved healthcare facilities. The disorder is even more common in East Asia (Japan and China) than other parts of Asia. However, as with healthcare in general, there remains extremely high rates of underdiagnosis in much of South Asia and Southeast Asia due to lack of access to care and low levels of awareness. As healthcare development improves and Asian populations age over the next couple of decades, the disease burden of Parkinson’s disease in Asia will likely worsen.
If you’re interested in specific statistics or further research on Parkinson’s disease in a particular country, feel free to ask!
Parkinson’s disease (PD) is a neurodegenerative disorder that aggravates over time. Parkinson’s disease progression varies from one individual to another but often follows a trend of gradual worsening in both motor and non-motor functions. Progression of Parkinson’s disease can be categorized into various stages, wherein the symptoms worsen as the disease develops.
Key Stages of Parkinson’s Disease Progression:
1. Early Stage (Mild Symptoms)
Motor Symptoms: In the beginning, PD usually involves only one side of the body (unilateral symptoms). The motor symptoms are usually minor and may not cause much discomfort in daily life. Early signs and symptoms are:
Resting tremors (trembling in one hand or finger)
Bradykinesia (slowness in movement)
Muscle stiffness or rigidity
Decreased facial expression (masked face)
Minimal handwriting changes (micrographia)
Mild balance impairment (but no extensive falls yet)
Non-Motor Symptoms: Early non-motor symptoms may be sleep disturbances, minor depression, and constipation. These symptoms might be extremely subtle and may pass unnoticed in the initial stages.
2. Moderate Stage (Worsening of Symptoms)
Increased Motor Symptoms: As PD progresses, symptoms generally become more obvious and involve both sides of the body (bilateral symptoms). People may begin to notice:
More obvious tremors affecting both sides of the body
More muscle stiffness and rigidity
Slower movements that interfere with daily functioning
Postural instability and balance impairment, leading to falls risk
Shuffling gait (reduced steps and also inability to lift feet)
Freezing of gait, where the person may feel as if their feet are stuck to the ground
Medication Adjustment: By this time, the patient may have to adjust the medication since the effectiveness of the first drug therapy (e.g., levodopa) will begin to decrease, and variation in movements (e.g., “on-off” periods) may begin to develop.
Non-Motor Symptoms: Cognitive impairments may start to manifest, such as memory impairments, difficulty with planning, and slowing of thought. Depression and anxiety become evident. Sleep disruptions (e.g., excessive waking and vivid dreams) are characteristic.
3. Advanced Stage (Severe Symptoms)
Severe Motor Symptoms: In the advanced stage, motor symptoms significantly impact daily functioning. The individual may develop:
Severe tremors that can make it difficult to perform daily activities like eating or dressing
Severe bradykinesia, which prevents it from initiating or completing movement
Severe rigidity, which can lead to pain and discomfort
Severe balance problems leading to falls
Walking difficulty and inability to walk independently
Freezing episodes can be more frequent, and the patient might need help with mobility
Complications: Complications such as dysphagia (swallowing difficulty) can be seen in advanced Parkinson’s patients that will leave them at greater risk for choking or aspiration pneumonia. They will have difficulty speaking (hypophonia), leading to a weaker, softer voice.
Cognitive and Psychiatric Symptoms: As PD advances, cognitive impairment may become more significant. Patients may develop Parkinson’s disease dementia (PDD), which can include symptoms like loss of memory, difficulty concentrating, and confusion. Hallucinations and delusions may also occur. Depression, anxiety, and apathy may become more evident.
Autonomic Dysfunction: People with advanced PD may also develop symptoms like orthostatic hypotension (low blood pressure when standing), sweating, urinary problems, and constipation.
4. End-Stage (Severe Disability)
Motor and Cognitive Decline: Patients in the final stages of Parkinson’s disease are completely dependent on their caregivers for everything. They are unable to walk or move even without assistance and may need help with eating, dressing, and personal hygiene.
Severe Cognitive and Behavioral Symptoms: Severe cognitive impairment, such as Parkinson’s disease dementia, manifests more clearly and leads to severe memory loss, confusion, and communication difficulties.
Physical Decline: Physical decline becomes more apparent during the last stage. There are greater chances of acquiring complications such as infections, pneumonia, and pressure sores, especially if the person is bedridden. Swallowing is more impaired, and the person is more vulnerable to choking and aspiration.
Death: Parkinson’s disease itself is not typically fatal, but deaths can occur due to disease complications, including pneumonia or aspiration pneumonia. The disease itself can cause prolonged disability and frailty, and people can die of immobility-related complications.
Factors That Influence Disease Progression:
Age of Onset: The earlier the onset of Parkinson’s disease, the more slowly it may progress. Younger patients may have slower progression and more favorable long-term function compared with older patients.
Response to Medication: Those who respond well to dopamine replacement therapy (e.g., levodopa) may have slower progression of motor symptoms. But as the illness advances, the response to drugs becomes less consistent.
Severity of Symptoms: The severity and type of symptoms at the time of diagnosis may influence the rate of disease progression. Patients with severe tremor or significant early cognitive impairment might experience more rapid progression.
Other Health Factors: Medical conditions, such as heart disease, diabetes, or stroke, may aggravate the progression of Parkinson’s disease and its complications.
Conclusion:
Parkinson’s disease is progressive in nature, and its rate of progress varies greatly from individual to individual. The disease affects motor and non-motor functions and worsens as the disease advances. Early intervention with medication, physical therapy, and other supportive treatments can reduce symptoms and improve quality of life, while the course of the disease is typically characterized by progressive loss of motor and cognitive function. Creation of more specific treatments and interventions is critical to decrease progression and improve outcomes in individuals with Parkinson’s disease.
The Parkinson’s Protocol™ By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease. The creator of this program has divided into four segments to cover a complete plan to treat this disease along with improving your health and life by knowing everything about this health problem. The main focus of this program is on boosting the levels of hormone in your brain by making e a few easy changes in your lifestyle, diet, and thoughts